Join Our Movement to Restore Your Right to Pain Relief! #EndPainPatientAbuse

Pain Warriors Unite - (202) 792-5600

Pain Warriors Unite

Calling ALL Pain Warriors, It's NOW or NEVER!

Pain Warriors Unite

Calling ALL Pain Warriors, It's NOW or NEVER!


Fellow Pain Warriors --

We must UNITE to fight for the Rights of Millions of Pain Patients! 


Click Below get involved NOW!

image121
image122

Fellow Pain Warriors --

We must UNITE to fight for the Rights of Millions of Pain Patients! 


Click Below get involved NOW!

image123

**URGENT ACTION ALERT**

Call to schedule a meeting with YOUR REPRESENTATIVES

U.S. CONGRESS WILL BE ON BREAK 

FOR THE MONTH OF AUGUST. 


The upcoming August recess is a great opportunity for you to set up a private meeting with your members of Congress or to attend any local Events (Town Hall Meetings,  Meet & Greets,  Campaign Events,  etc.) to address our cause.   


CLICK HERE TO LOCATE YOUR STATE & FEDERAL REPRESENTATIVES 


You can find upcoming events in your State HERE: https://indivisible.org/events


Please let us know if you need assistance setting up a meeting or if you'd like a packet of materials to bring along. 


Legislative Outreach Kit

Instructions ,  Tips, and Links to locate & Contact Your State and Federal Representatives & Regulatory Agencies


 Please use our handy Legislative Outreach Kit & ask for assistance if necessary.   The only way to change the current pathway which has created a hostile regulatory environment is to GET INVOLVED IN THE LEGISLATIVE PROCESS ASAP 

Click Here
image124

Pain Management Task Force Meeting overview

RE: Overview of Pain Management Task Force Meeting & Recommendations



View Task Force's Final Report HERE


The purpose of this final meeting was for the Task Force members to disseminate and discuss the final report in full detail. They debated and deliberated to carefully refine the language and terminology to avoid future misinterpretation or misapplication. They reviewed the consensus of thousands of comments submitted by the public during the previous public comment

Summary:


Click Below for our Summary of the Meeting 

Meeting Summary
image125

Urgent Press Release from CDC

Please Get Involved Now

Meet with Your Representatives

image189

What can YOU do to help?


  • CALL & MEET WITH YOUR  REPRESENTATIVES ASAP!  



If you need help,  please let us know & we'll be happy to provide the information you'll need!


It's best to call their local offices directly  and request to schedule a meeting or telephone conference with their health care staffer, 


CLICK BELOW TO LOCATE & CONTACT YOUR STATE AND FEDERAL REPRESENTATIVES DURING BUSINESS HOURS!

Contact Your Representatives
image190

National News Coverage About Harmful effects on CPP'S

April 26th report by Shepard Smith about the harms to chronic pain patients as a result of the overarching CDC Guidelines. 


Link to Video:  https://youtu.be/2Jg0ZV9ftFE


-----------------------------


Fox News' Greg Gutfeld has been reporting about our plight for several months.  Watch the most recent segment about the CDC Clarification featured on "The Five"


Watch segment here:  

https://video.foxnews.com/v/6024911665001/?playlist_id=1040983441001#sp=show-clips

image191

URGENT BULLETIN

** URGENT BULLETIN ** Please SHARE with all State& Federal Representatives and Regulatory Agencies in charge of regulating Controlled Substances/Opioid prescribing. 


Re:  CDC Guideline Clarification Letter & FDA Advisory Notice pertaining to Opioid Prescribing 


Below is a letter from the CDC clarifying the 2016 Opioid Prescribing  Guideline and an Advisory Notice issued by the FDA regarding abrupt opioid tapering. 


Link to Clarification Letter from the CDC: CLICK  HERE


The Guideline is not intended to deny any patients who suffer with chronic pain from receiving opioid therapy as an option for pain management. Rather, the Guideline is intended to ensure that clinicians and patients consider all safe and effective treatment options for patients. 


Clinical decision-making should be based on the relationship between the clinician and patient, with an understanding of the patient’s clinical situation, functioning, and life context, as well as a careful consideration of the benefits and risk of all treatment options, including opioid therapy. 


CDC encourages physicians to continue to use their clinical judgment and base treatment on what they know about their patients, includes the use of opioids if determined to be the best course of treatment. Providers should communicate frequently with their patients to discuss both the benefits and risks of opioid therapy and revisit treatment plans for pain regularly to achieve the most positive outcomes for patients. 


Link to FDA Announcement CLICK HERE  


Reports of "serious harm" in patients dependent on opioid painkillerswho suddenly stop taking the medication, or rapidly decrease the dose, have prompted a drug safety communication issued today by the US Food and Drug Administration (FDA).

image192

HIPPA & PATIENTS PRIVACY

HIPPA and the opioid crisis


The U.S. Department of Health and Human Services Office for Civil Rights has released new guidance explaining when HIPAA permits health care providers and other covered entities to share a patient’s health information with loved ones and others involved in a patient’s care in these situations.


The guidance explains:


  • Providers can share information with an individual patient's loved ones in certain emergency or dangerous situations, such as when the patient is in a crisis and incapacitated, or is facing a serious and imminent threat of harm.


  • Patients with decision-making capacity retain their right to decide when and whether their information will be shared, unless there is a serious and imminent threat of harm.


  • Patients' personal representatives, who have authority under state law to make health care decisions for patients, may request and obtain information on behalf of patients.


View the guidance.


image193

URGENT PRESS RELEASE FROM HP3 - RE: CDC GUIDELINE

 **** Attention ALL CPP'S ****


**URGENT PRESS RELEASE**  2nd LETTER FROM CDC RESPONDING TO THE HP3 LETTER RELEASED TODAY! 


https://healthprofessionalsforpatientsinpain.org/press-release


FOR IMMEDIATE RELEASE APRIL 10, 2019


TWO FEDERAL AGENCIES SPEAK AGAINST MANDATED OR PRECIPITOUS OPIOID REDUCTIONS IN CHRONIC PAIN PATIENTS 


On April 10, the Director for the Centers for Disease Control and Prevention, Dr. Robert Redfield, wrote to Health Professionals for Patients in Pain (HP3) to state that the CDC’s 2016 Guideline offered no support for mandatory opioid dose reductions in patients with long-term pain. Coming on the heels of an April 9 warning from the United States Food and Drug Administration of “serious harm” to patients after rapid dose reduction or discontinuation, the Director’s letter flags the need for a recalibration of care decisions imposed by a wide range of private and governmental agencies that have invoked the CDC to justify coverage restrictions, quality metrics, legal threats and other actions to force dose reductions on nonconsenting patients.



Please CLICK BELOW to read Press Release & Access the CDC Director's Letter responding to the HP3 Letter 



CDC LETTER HERE
image194

Did Your State's Attorney General Sign this Letter?

The National Association of Attorneys General (NAAG) has sent a letter to the U.S. Department of Health and Human Services (HHS) sharing concerns about the Pain Management Best Practices Inter-Agency Task Force Draft Report (Draft Report). The letter was addressed to Dr. Vanila Singh, chief medical officer for the Office of the Assistant Secretary for Health. 


As it stands, the Draft Report deviates from guidelines published by the Centers for Disease Control and Prevention (CDC), which are aimed at decreasing the risk of opioid misuse. The report suggests providers can rely solely on their judgement instead of consulting evidence-based recommendations. By doing so, it weakens recommendations for opioid prescription duration and dosage


“As attorneys general, we have witnessed the devastating effect of unfettered opioid manufacturing, distribution and prescribing on our public health, social services and criminal justice systems. The well-established risks associated with higher doses of opioids, prescriptions of longer duration, and concurrent prescriptions of opioids and benzodiazepines demand continued constraints.” 



Read the NAAG letter signed by 39 state and territory attorneys general


If your State Attorney General signed this damning letter to the Pain Management Task Force, please call or email him/her to share your disdain & disappointment. Also, request To schedule a meeting. 


Find your Attorney General HERE 



Click button to read the letter to the Task Force in its entirety. 

READ LETTER HERE

Change Starts with YOU!

image195

Please get involved NOW by completing the latest Calls to Action and Team Tasks. 


Our collective efforts are making a HUGE difference no matter how big or small. 


We need YOU to take the time to do whatever you can to be victorious in this fight for our LIVES. 


CLICK BELOW TO COMPLETE THE LATEST TEAM TASKS. 

Click Here

Send a Unique Video Message or Email to Your Representatives

Featured Websites & Groups

image196

Want to Have Your Website or Group Featured Here to Drive New Members Your Way?  


Click BELOW for Instructions. 

Find out more

Stay in the Know

Sign up to Stay up to Date on the Latest News, Alerts, Deadlines, Calls to Action & Events Happening in the Pain Community.

Check out our Twitter Feed

Contact Us

Do You Have a Question or Want to Share Your Thoughts? Please Use this Form to Contact Our Team.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.